EpiCept Articles
Myrexis returns rights to Azixa to EpiCept
6 September 2012
Meda debuts leukemia drug Ceplene in the UK
20 January 2011
EpiCept shares hammered as FDA calls for additional study on AML drug candidate Ceplene
24 August 2010
Showing 1-7 of 7 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
